Hydreight Technologies Inc. (“
Hydreight” or
the
“Company”) ( TSXV:
NURS )( OTCQB: HYDTF )( FSE: SO6 ), a
fast-growing mobile clinical network and medical platform which
enables flexible at-home medical services across 50 states in the
United States, is pleased to announce that it received a
Companies-to-Watch award as part of the 2023
Deloitte Technology Fast 50™ program. Celebrating its 26th
anniversary, the award recognizes emerging companies based on their
revenue growth percentage.
Shane Madden, CEO of Hydreight
commented, “We are thrilled to receive a Companies-to-Watch award
for 2023, from the esteemed Deloitte Technology Fast 50™ program.
This award not only highlights the Company’s significant organic
revenue growth of 250% YoY, but also validates our business
operations and key differentiators we have in the market. We are
building the largest mobile clinical network across the United
States, and are one of the only proprietary, full-integrated
platforms that allows nurses to legally provide at home services in
over 650 cities across 50 states. We would like to thank Deloitte
for their consideration and support of Hydreight and what we are
building. This has been an incredible year of growth for Hydreight,
and we look forward to continuing that trajectory in 2024 and
beyond.”
The Companies-to-watch category is a ranking of
Canadian technology companies with the potential to be future
Technology Fast 50™ candidates by their revenue growth percentage
over their last three years of operation. The winners of this
year’s companies to watch category must have a minimum revenue of
$50,000 in 2020 and $2.5 million in 2022.
“Congratulations to this year’s
Companies-to-Watch winners,” commented Anders McKenzie,
partner and national leader for the Technology Fast 50 program at
Deloitte Canada. “These companies have demonstrated
promising growth trajectories and an exemplary ability to seize
opportunities even in the face of a challenging economic context.
This sets them apart as members of an emerging cohort of tech
leaders in Canada. We look forward to keeping an eye on their
progress in the months and years to come.”
About the Deloitte Technology Fast 50™
program
The Deloitte Technology Fast 50 program is
Canada’s pre-eminent technology awards program. Celebrating its
26th anniversary, the program recognizes business growth,
innovation, and entrepreneurship in four distinct categories:
Technology Fast 50 ranking, Enterprise—Industry leaders, Clean
Technology, and Companies-to-Watch. The program also
recognizes companies within the North American Technology Fast 500
ranking, identifying thriving technology companies in the United
States and Canada. The 2023 program sponsors include Deloitte,
RBCx, Osler, EDC, CCI, TMX, Clarity, and Lafond. For further
information, visit www.fast50.ca.
About Hydreight Technologies
Inc.
Hydreight Technologies Inc. is building the
largest mobile clinic network in the United States. Its
proprietary, fully integrated platform hosts a network of over 2500
nurses, over 100 doctors and a pharmacy network across 50 states.
The platform includes a built-in, easy-to-use suite of fully
integrated tools for accounting, documentation, sales, inventory,
booking, and managing patient data, which enables licensed
healthcare professionals to provide services directly to patients
at home, office or hotel. Hydreight is bridging the gap between
provider compliance and patient convenience, empowering nurses, med
spa technicians, and other licensed healthcare professionals. The
Hydreight platform allows healthcare professionals to deliver
services independently, on their own terms, or to add mobile
services to existing location-based operations. Hydreight has a
503B pharmacy network servicing all 50 states and is closely
affiliated with a U.S. certified e-script and telemedicine provider
network that provides services in over 650 cities and
growing.
On behalf of the Board of Directors
Shane MaddenDirector and Chief Executive OfficerHydreight
Technologies Inc.
Contact
Email: ir@hydreight.com; Telephone:
(480) 790 6886
Cautionary Note Regarding
Forward-Looking Information
This press release contains statements which
constitute “forward-looking information” within the meaning of
applicable securities laws, including statements regarding the
plans, intentions, beliefs and current expectations of the Company
with respect to future business activities and operating
performance. Forward-looking information is often identified by the
words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”,
“anticipate”, “believe”, “estimate”, “expect”, “Approximately” or
similar expressions and includes information regarding the launch
date of MedicalMedIV.com, and the anticipated effect on bookings
and customer retention rates.
Investors are cautioned that forward-looking
information is not based on historical facts but instead reflects
the Company’s management’s expectations, estimates or predictions
concerning future results or events based on the opinions,
assumptions and estimates of management considered reasonable at
the date the statements are made. Although the Company believes
that the expectations reflected in such forward-looking information
are reasonable, such information involves risks and uncertainties,
and undue reliance should not be placed on such information, as
unknown or unpredictable factors could have material adverse
effects on future results, performance or achievements of the
Company. Among the key factors that could cause actual results to
differ materially from those projected in the forward-looking
information are the following: the ability to obtain requisite
regulatory and other approvals with respect to the business
operated by the Company and/or the potential impact of the listing
of the Company’s shares on the TSXV on relationships, including
with regulatory bodies, employees, suppliers, customers and
competitors; changes in general economic, business and political
conditions, including changes in the financial markets; changes in
applicable laws; compliance with extensive government regulation;
and the diversion of management time as a result of being a
publicly listed entity. This forward-looking information may be
affected by risks and uncertainties in the business of the Company
and market conditions.
Should one or more of these risks or
uncertainties materialize, or should assumptions underlying the
forward-looking information prove incorrect, actual results may
vary materially from those described herein as intended, planned,
anticipated, believed, estimated or expected. Although the Company
has attempted to identify important risks, uncertainties and
factors which could cause actual results to differ materially,
there may be others that cause results not to be as anticipated,
estimated or intended. The Company does not intend, and does not
assume any obligation, to update this forward-looking information
except as otherwise required by applicable law.
Neither TSXV nor its Regulation Services
Provider (as that term is defined in policies of the TSXV) accepts
responsibility for the adequacy or accuracy of this release.
This press release does not constitute an offer
of securities for sale in the United States. The securities being
offered have not been, nor will they be, registered under the
United States Securities Act of 1933, as amended, and such
securities may not be offered or sold within the United States
absent U.S. registration or an applicable exemption from U.S.
registration requirements.
Grafico Azioni Hydreight Technologies (TSXV:NURS)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Hydreight Technologies (TSXV:NURS)
Storico
Da Giu 2023 a Giu 2024